Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Galloway JB"" wg kryterium: Autor


Tytuł:
The Clinical Impact of Electronic Patient-Reported Outcome Measures in the Remote Monitoring of Inflammatory Arthritis: A Systematic Review and Meta-analysis.
Autorzy:
Arumalla N; King's College London, London, UK.
Chan CKD; King's College London, London, UK.
Gibson M; Guy's and St Thomas' NHS Trust, London, UK.
Man YL; Lewisham and Greenwich NHS Trust, London, UK.
Adas MA; King's College London, London, UK.
Norton S; King's College London, London, UK.
Galloway JB; King's College London, London, UK.
Garrood T; Guy's and St Thomas' NHS Trust, London, UK.
Pokaż więcej
Źródło:
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2023 Nov; Vol. 75 (11), pp. 1892-1903. Date of Electronic Publication: 2023 Sep 18.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Arthritis, Rheumatoid*/drug therapy
Patient Reported Outcome Measures*
Monitoring, Physiologic*
Humans ; Remote Sensing Technology
Czasopismo naukowe
Tytuł:
Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional survey.
Autorzy:
Quirke-McFarlane S; School of Cancer and Pharmaceutical Sciences.; School of Psychology, University of Surrey, UK.
Weinman J; School of Cancer and Pharmaceutical Sciences.
Cook ES; Centre for Rheumatic Diseases.
Yiu ZZN; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
Dand N; Department of Medical and Molecular Genetics.
Langan SM; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London.; Faculty of Epidemiology, and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Bechman K; Centre for Rheumatic Diseases.
Tsakok T; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London.
Mason KJ; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.; School of Medicine, Keele University, Keele, UK.
McAteer H; The Psoriasis Association, Northampton, UK.
Meynell F; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London.
Coker B; NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Vincent A; NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Urmston D; The Psoriasis Association, Northampton, UK.
Vesty A; The Psoriasis Association, Northampton, UK.
Kelly J; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
Lancelot C; International Federation of Psoriasis Associations, France.
Moorhead L; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London.
Barbosa IA; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London.
Bachelez H; Department of Dermatology, AP-HP Hôpital Saint-Louis, Paris, France.; INSERM U1163, Imagine Institute for Human Genetic Diseases, Université de Paris, Paris, France.
Capon F; Department of Medical and Molecular Genetics.; NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Contreras CR; Catedra de Dermatologia, Hospital de Clinicas, Facultad de Ciencias Medicas, Universidad Nacional de Asuncion, Paraguay.
De La Cruz C; Clinica Dermacross, Santiago, Chile.
Di Meglio P; NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; St John's Institute of Dermatology (School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine).
Gisondi P; Section of Dermatology and Venereology, University of Verona, Verona, Italy.
Jullien D; Department of Dermatology, Edouard Herriot Hospital, Hospices Civils de Lyon, University of Lyon, Lyon, France.; Groupe de Recherche sur le Psoriasis (GrPso) de la Société Française de Dermatologie, Paris, France.
Lambert J; Department of Dermatology, Ghent University, Ghent, Belgium.
Naldi L; Centro Studi GISED, Bergamo, Italy.
Puig L; Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
Spuls P; Department of Dermatology, Amsterdam Public Health/Infection and Immunology, Amsterdam University Medical Centers, Location AMC, Amsterdam, the Netherlands.
Torres T; Department of Dermatology, Centro Hospitalar do Porto, Portugal.
Warren RB; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
Waweru H; International Federation of Psoriasis Associations, France.
Galloway JB; Centre for Rheumatic Diseases.
Griffiths CEM; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
Barker JN; NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; St John's Institute of Dermatology (School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine).
Norton S; Psychology Department (Institute of Psychiatry, Psychology and Neuroscience), King's College London, London, UK.
Smith CH; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London.; NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Mahil SK; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London.; NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Pokaż więcej
Corporate Authors:
PsoProtect study group
Źródło:
The British journal of dermatology [Br J Dermatol] 2023 Apr 20; Vol. 188 (5), pp. 610-617.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
Psoriasis*/drug therapy
Psoriasis*/epidemiology
Humans ; Cross-Sectional Studies ; Pandemics ; Anxiety/epidemiology ; Anxiety/psychology ; Depression/epidemiology
Czasopismo naukowe
Tytuł:
Rising incidence of Pneumocystis pneumonia: A population-level descriptive ecological study in England.
Autorzy:
Pates K; Department of Respiratory Medicine, Kings College Hospital, Kings College Hospital NHS Foundation Trust, London, UK. Electronic address: .
Periselneris J; Department of Respiratory Medicine, Kings College Hospital, Kings College Hospital NHS Foundation Trust, London, UK.
Russell MD; Centre for Rheumatic Diseases, King's College London, SE5 9RJ, UK.
Mehra V; Department of Haematology, Kings College Hospital, Kings College Hospital NHS Foundation Trust, London, UK.
Schelenz S; Department of Microbiology, Kings College Hospital, Kings College Hospital NHS Foundation Trust, London, UK.
Galloway JB; Centre for Rheumatic Diseases, King's College London, SE5 9RJ, UK.
Pokaż więcej
Źródło:
The Journal of infection [J Infect] 2023 Apr; Vol. 86 (4), pp. 385-390. Date of Electronic Publication: 2023 Feb 10.
Typ publikacji:
Journal Article
MeSH Terms:
Pneumonia, Pneumocystis*/epidemiology
Pneumonia, Pneumocystis*/microbiology
Opportunistic Infections*
Humans ; Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use ; Incidence ; England/epidemiology ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Changing trends in ethnicity and academic performance: observational cohort data from a UK medical school.
Autorzy:
Mukherji P; Marketing Department, King's College London, London, UK.
Adas MA; Centre for Rheumatic Diseases, King's College London, London, UK.
Clarke B; Postgraduate Medical & Dental Education Centre, King's College Hospital NHS Foundation Trust, London, UK.
Galloway JB; Centre for Rheumatic Diseases, King's College London, London, UK james.galloway@kcl.ac.uk.
Mulvey T; Clinical Education Department, King's College London, London, UK.
Norton S; Psychology Department, Insitute of Psychiatry, King's College London, London, UK.
Turner J; Clinical Education Department, King's College London, London, UK.
Russell MD; Centre for Rheumatic Diseases, King's College London, London, UK.
Lempp H; Centre for Rheumatic Diseases, King's College London, London, UK.
Li S; Division of Medical Education, King's College London, London, UK.
Pokaż więcej
Źródło:
BMJ open [BMJ Open] 2022 Dec 15; Vol. 12 (12), pp. e066886. Date of Electronic Publication: 2022 Dec 15.
Typ publikacji:
Observational Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Schools, Medical*
Students, Medical*
Adult ; Female ; Humans ; Adolescent ; Male ; Ethnicity ; Educational Measurement ; United Kingdom
Czasopismo naukowe
Tytuł:
Vaccine hesitancy and access to psoriasis care during the COVID-19 pandemic: findings from a global patient-reported cross-sectional survey.
Autorzy:
Bechman K; Centre for Rheumatic Diseases, King's College London, London, UK.
Cook ES; Centre for Rheumatic Diseases, King's College London, London, UK.
Dand N; Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.; Health Data Research UK, London, UK.
Yiu ZZN; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
Tsakok T; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Meynell F; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Coker B; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Vincent A; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Bachelez H; Department of Dermatology, AP-HP Hôpital Saint-Louis, Paris, France.; INSERM U1163, Imagine Institute for Human Genetic Diseases, Université de Paris, Paris, France.
Barbosa I; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Brown MA; Centre for Rheumatic Diseases, King's College London, London, UK.; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Capon F; Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Contreras CR; Catedra de Dermatologia, Hospital de Clinicas, Facultad de Ciencias Medicas, Universidad Nacional de Asuncion, Paraguay.
De La Cruz C; Clinica Dermacross, Santiago, Chile.
Meglio PD; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; St John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
Gisondi P; Section of Dermatology and Venereology, University of Verona, Verona, Italy.
Jullien D; Department of Dermatology, Edouard Herriot Hospital, Hospices Civils de Lyon, University of Lyon, Lyon, France.; Groupe de recherche sur le psoriasis (GrPso) de la Société Française de dermatologie, Paris, France.
Kelly J; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
Lambert J; Department of Dermatology, Ghent University, Ghent, Belgium.
Lancelot C; International Federation of Psoriasis Associations.
Langan SM; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; Faculty of Epidemiology, and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Mason KJ; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.; School of Medicine, Keele University, Keele, UK.
McAteer H; The Psoriasis Association, Northampton, UK.
Moorhead L; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Naldi L; Centro Studi GISED, Bergamo, Italy.
Norton S; Psychology Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Puig L; Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
Spuls PI; Department of Dermatology, Amsterdam Public Health/Infection and Immunology, Amsterdam University Medical Centers, Location AMC, Amsterdam, the Netherlands.
Torres T; Department of Dermatology, Centro Hospitalar do Porto, Portugal.
Urmston D; The Psoriasis Association, Northampton, UK.
Vesty A; The Psoriasis Association, Northampton, UK.
Warren RB; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
Waweru H; International Federation of Psoriasis Associations.
Weinman J; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
Griffiths CEM; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
Barker JN; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; St John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
Smith CH; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Galloway JB; Centre for Rheumatic Diseases, King's College London, London, UK.
Mahil SK; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Pokaż więcej
Corporate Authors:
PsoProtect study group
Źródło:
The British journal of dermatology [Br J Dermatol] 2022 Aug; Vol. 187 (2), pp. 254-256. Date of Electronic Publication: 2022 May 03.
Typ publikacji:
Letter
MeSH Terms:
COVID-19*/prevention & control
Psoriasis*/drug therapy
Cross-Sectional Studies ; Humans ; Pandemics ; Patient Reported Outcome Measures ; Vaccination ; Vaccination Hesitancy
Opinia redakcyjna
Tytuł:
Management of gout following 2016/2017 European (EULAR) and British (BSR) guidelines: An interrupted time-series analysis in the United Kingdom.
Autorzy:
Russell MD; Centre for Rheumatic Diseases, King's College London, SE5 9RJ, UK.
Rutherford AI; Department of Rheumatology, King's College Hospital NHS Foundation Trust, London, SE5 9RS, UK.
Ellis B; Department of Rheumatology, Imperial College Healthcare NHS Foundation Trust, London.
Norton S; Centre for Rheumatic Diseases, King's College London, SE5 9RJ, UK.
Douiri A; School of Population Health and Environmental Sciences, King's College London, SE1 1UL, UK.
Gulliford MC; School of Population Health and Environmental Sciences, King's College London, SE1 1UL, UK.
Cope AP; Centre for Rheumatic Diseases, King's College London, SE5 9RJ, UK.
Galloway JB; Centre for Rheumatic Diseases, King's College London, SE5 9RJ, UK.
Pokaż więcej
Źródło:
The Lancet regional health. Europe [Lancet Reg Health Eur] 2022 May 25; Vol. 18, pp. 100416. Date of Electronic Publication: 2022 May 25 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Inpatient COVID-19 mortality has reduced over time: Results from an observational cohort.
Autorzy:
Bechman K; Centre for Rheumatic Diseases, King's College London, London, United Kingdom.
Yates M; Centre for Rheumatic Diseases, King's College London, London, United Kingdom.
Mann K; Centre for Rheumatic Diseases, King's College London, London, United Kingdom.
Nagra D; Centre for Rheumatic Diseases, King's College London, London, United Kingdom.
Smith LJ; King's College Hospital NHS Foundation Trust, London, United Kingdom.
Rutherford AI; King's College Hospital NHS Foundation Trust, London, United Kingdom.
Patel A; King's College Hospital NHS Foundation Trust, London, United Kingdom.
Periselneris J; King's College Hospital NHS Foundation Trust, London, United Kingdom.
Walder D; King's College Hospital NHS Foundation Trust, London, United Kingdom.
Dobson RJB; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.; NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, United Kingdom.; Health Data Research UK London, University College London, London, United Kingdom.
Kraljevic Z; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Teo JHT; King's College Hospital NHS Foundation Trust, London, United Kingdom.; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Bernal W; King's College Hospital NHS Foundation Trust, London, United Kingdom.; School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.
Barker R; Centre for Rheumatic Diseases, King's College London, London, United Kingdom.
Galloway JB; Centre for Rheumatic Diseases, King's College London, London, United Kingdom.
Norton S; Centre for Rheumatic Diseases, King's College London, London, United Kingdom.; Psychology Department, King's College London, London, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Jan 13; Vol. 17 (1), pp. e0261142. Date of Electronic Publication: 2022 Jan 13 (Print Publication: 2022).
Typ publikacji:
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19/*mortality
Hospital Mortality/*trends
Inpatients/*statistics & numerical data
Adenosine Monophosphate/analogs & derivatives ; Adenosine Monophosphate/therapeutic use ; Aged ; Alanine/analogs & derivatives ; Alanine/therapeutic use ; Cohort Studies ; Comorbidity/trends ; Dexamethasone/therapeutic use ; Female ; Hospitalization/statistics & numerical data ; Humans ; London ; Male ; Middle Aged ; Pandemics/statistics & numerical data ; Patient Discharge/statistics & numerical data ; Proportional Hazards Models ; COVID-19 Drug Treatment
Czasopismo naukowe
Tytuł:
Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study.
Autorzy:
Mahil SK; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Yates M; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; Centre for Rheumatic Diseases, King's College London, London, UK.
Yiu ZZN; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
Langan SM; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; Faculty of Epidemiology, and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Tsakok T; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Dand N; Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.; Health Data Research UK, London, UK.
Mason KJ; Centre for Rheumatic Diseases, King's College London, London, UK.; School of Medicine, Keele University, Keele, UK.
McAteer H; The Psoriasis Association, Northampton, UK.
Meynell F; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Coker B; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Vincent A; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Urmston D; The Psoriasis Association, Northampton, UK.
Vesty A; The Psoriasis Association, Northampton, UK.
Kelly J; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
Lancelot C; International Federation of Psoriasis Associations (IFPA), Bromma, Sweden.
Moorhead L; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Bachelez H; Department of Dermatology, AP-HP Hôpital Saint-Louis, Paris, France.; INSERM U1163, Imagine Institute for Human Genetic Diseases, Université de Paris, Paris, France.
Capon F; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Contreras CR; Catedra de Dermatologia, Hospital de Clinicas, Facultad de Ciencias Medicas, Universidad Nacional de Asuncion, San Lorenzo, Paraguay.
De La Cruz C; Clinica Dermacross, Santiago, Chile.
Di Meglio P; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; St John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
Gisondi P; Section of Dermatology and Venereology, University of Verona, Verona, Italy.
Jullien D; Department of Dermatology, Edouard Herriot Hospital, Hospices Civils de Lyon, University of Lyon, Lyon, France.; Groupe de Recherche sur le Psoriasis (GrPso) de la Société Française de Dermatologie, Paris, France.
Lambert J; Department of Dermatology, Ghent University, Ghent, Belgium.
Naldi L; Centro Studi GISED, Bergamo, Italy.
Norton S; Psychology Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Puig L; Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Spuls P; Department of Dermatology, Amsterdam Public Health/Infection and Immunology, Amsterdam University Medical Centers, Location AMC, Amsterdam, The Netherlands.
Torres T; Department of Dermatology, Centro Hospitalar do Porto, Porto, Portugal.
Warren RB; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
Waweru H; International Federation of Psoriasis Associations (IFPA), Bromma, Sweden.
Weinman J; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
Brown MA; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; Centre for Rheumatic Diseases, King's College London, London, UK.
Galloway JB; Centre for Rheumatic Diseases, King's College London, London, UK.; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
Griffiths CM; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
Barker JN; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; St John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
Smith CH; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Pokaż więcej
Corporate Authors:
PsoProtect study group
Źródło:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2021 Oct; Vol. 35 (10), pp. e636-e640. Date of Electronic Publication: 2021 Aug 19.
Typ publikacji:
Letter
MeSH Terms:
COVID-19*
Psoriasis*/epidemiology
Cross-Sectional Studies ; Humans ; Pandemics ; SARS-CoV-2
Opinia redakcyjna
Tytuł:
Nonserious Infections in Patients With Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
Autorzy:
Bechman K; Kings College London, London, UK.
Halai K; Kings College London, London, UK.
Yates M; Kings College London, London, UK.
Norton S; Kings College London, London, UK.
Cope AP; Kings College London, London, UK.
Hyrich KL; Manchester Academic Health Sciences Centre, University of Manchester, NIHR Manchester Biomedical Research Centre, and Manchester University NHS Foundation Trust, Manchester, UK.
Galloway JB; Kings College London, London, UK.
Pokaż więcej
Corporate Authors:
British Society for Rheumatology Biologics Register for Rheumatoid Arthritis Contributors Group
Źródło:
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2021 Oct; Vol. 73 (10), pp. 1800-1809. Date of Electronic Publication: 2021 Aug 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antirheumatic Agents/*therapeutic use
Arthritis, Rheumatoid/*epidemiology
Biological Products/*therapeutic use
Infections/*epidemiology
Tumor Necrosis Factor Inhibitors/*therapeutic use
Adult ; Aged ; Arthritis, Rheumatoid/drug therapy ; Comorbidity ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Registries ; United Kingdom/epidemiology
Czasopismo naukowe
Tytuł:
Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey.
Autorzy:
Mahil SK
Yates M
Langan SM
Yiu ZZN
Tsakok T
Dand N
Mason KJ
McAteer H
Meynell F
Coker B
Vincent A
Urmston D
Vesty A
Kelly J
Lancelot C
Moorhead L
Bachelez H
Bruce IN
Capon F
Contreras CR
Cope AP
De La Cruz C
Di Meglio P
Gisondi P
Hyrich K
Jullien D
Lambert J
Marzo-Ortega H
McInnes I
Naldi L
Norton S
Puig L
Sengupta R
Spuls P
Torres T
Warren RB
Waweru H
Weinman J
Griffiths CEM
Barker JN
Brown MA
Galloway JB
Smith CH
Pokaż więcej
Corporate Authors:
PsoProtect, CORE-UK study groups
Źródło:
The British journal of dermatology [Br J Dermatol] 2021 Jul; Vol. 185 (1), pp. 80-90. Date of Electronic Publication: 2021 Mar 09.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Joint Diseases*
Cross-Sectional Studies ; Humans ; Male ; Pandemics ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
A Kawasaki-like illness in an adult with recent SARS-CoV-2 infection.
Autorzy:
Nagra D; Centre for Rheumatic Disease, King's College London.
Russell MD; Centre for Rheumatic Disease, King's College London.
Rosmini S; King's College Hospital NHS Foundation Trust, London, UK.
Sado D; King's College Hospital NHS Foundation Trust, London, UK.
Buazon A; Centre for Rheumatic Disease, King's College London.
Shafi T; King's College Hospital NHS Foundation Trust, London, UK.
Hamlyn E; King's College Hospital NHS Foundation Trust, London, UK.
Sandhu G; King's College Hospital NHS Foundation Trust, London, UK.
Rutherford AI; King's College Hospital NHS Foundation Trust, London, UK.
Galloway JB; Centre for Rheumatic Disease, King's College London.
Pokaż więcej
Źródło:
Rheumatology advances in practice [Rheumatol Adv Pract] 2021 May 18; Vol. 5 (2), pp. rkab035. Date of Electronic Publication: 2021 May 18 (Print Publication: 2021).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
IL-6 inhibition in the treatment of COVID-19: A meta-analysis and meta-regression.
Autorzy:
Tharmarajah E; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Buazon A; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Patel V; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Hannah JR; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Adas M; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Allen VB; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Bechman K; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Clarke BD; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Nagra D; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Norton S; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Russell MD; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK. Electronic address: .
Rutherford AI; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Yates M; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Galloway JB; Centre for Rheumatic Diseases, Weston Education Centre, King's College London, 10 Cutcombe Road, London SE5 9RJ, UK.
Pokaż więcej
Źródło:
The Journal of infection [J Infect] 2021 May; Vol. 82 (5), pp. 178-185. Date of Electronic Publication: 2021 Mar 18.
Typ publikacji:
Journal Article; Meta-Analysis
MeSH Terms:
COVID-19*
Interleukin-6*
Adult ; Humans ; Male ; Odds Ratio ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
Venous Thromboembolism Risk With JAK Inhibitors: A Meta-Analysis.
Autorzy:
Yates M; King's College London, London, UK.
Mootoo A; King's College London, London, UK.
Adas M; King's College London, London, UK.
Bechman K; King's College London, London, UK.
Rampes S; King's College London, London, UK.
Patel V; King's College London, London, UK.
Qureshi S; King's College London, London, UK.
Cope AP; King's College London, London, UK.
Norton S; King's College London, London, UK.
Galloway JB; King's College London, London, UK.
Pokaż więcej
Źródło:
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2021 May; Vol. 73 (5), pp. 779-788. Date of Electronic Publication: 2021 Mar 25.
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
MeSH Terms:
Janus Kinase Inhibitors/*therapeutic use
Pulmonary Embolism/*epidemiology
Venous Thromboembolism/*epidemiology
Venous Thrombosis/*epidemiology
Arthritis, Psoriatic/drug therapy ; Arthritis, Rheumatoid/drug therapy ; Azetidines/therapeutic use ; Clinical Trials, Phase II as Topic ; Clinical Trials, Phase III as Topic ; Heterocyclic Compounds, 3-Ring/therapeutic use ; Humans ; Inflammatory Bowel Diseases/drug therapy ; Piperidines/therapeutic use ; Psoriasis/drug therapy ; Purines/therapeutic use ; Pyrazoles/therapeutic use ; Pyridines/therapeutic use ; Pyrimidines/therapeutic use ; Randomized Controlled Trials as Topic ; Risk ; Spondylarthropathies/drug therapy ; Spondylitis, Ankylosing/drug therapy ; Sulfonamides/therapeutic use ; Triazoles/therapeutic use
Czasopismo naukowe
Tytuł:
Biological responses to COVID-19: Insights from physiological and blood biomarker profiles.
Autorzy:
Zakeri R; King's College London British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine & Sciences, London, SE5 9NU, UK; King's College Hospital NHS Foundation Trust, London, UK.
Pickles A; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.
Carr E; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Bean DM; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; Health Data Research UK London, University College London, London, UK.
O'Gallagher K; King's College London British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine & Sciences, London, SE5 9NU, UK.
Kraljewic Z; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Searle T; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.
Shek A; Department of Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Galloway JB; Centre for Rheumatic Diseases, King's College London, London, UK.
Teo JTH; King's College Hospital NHS Foundation Trust, London, UK; Department of Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Shah AM; King's College London British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine & Sciences, London, SE5 9NU, UK; King's College Hospital NHS Foundation Trust, London, UK.
Dobson RJB; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Institute of Health Informatics, University College London, London, UK; NIHR Biomedical Research Centre at University College London Hospitals NHS Foundation Trust, London, UK.
Bendayan R; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK. Electronic address: .
Pokaż więcej
Źródło:
Current research in translational medicine [Curr Res Transl Med] 2021 May; Vol. 69 (2), pp. 103276. Date of Electronic Publication: 2021 Feb 03.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers/*blood
COVID-19/*diagnosis
COVID-19/*epidemiology
COVID-19/*physiopathology
Aged ; Aged, 80 and over ; Biological Variation, Individual ; Body Temperature ; COVID-19/blood ; Cohort Studies ; Comorbidity ; Diagnostic Tests, Routine ; Disease Progression ; Female ; Heart Rate/physiology ; Humans ; Male ; Middle Aged ; Oxygen Consumption/physiology ; Prognosis ; Retrospective Studies ; Risk Assessment ; SARS-CoV-2/immunology ; SARS-CoV-2/pathogenicity ; Severity of Illness Index ; Socioeconomic Factors ; United Kingdom/epidemiology
Czasopismo naukowe
Tytuł:
Remote Measurement in Rheumatoid Arthritis: Qualitative Analysis of Patient Perspectives.
Autorzy:
White KM; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Ivan A; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Williams R; Department of Academic Rheumatology, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
Galloway JB; The Centre for Rheumatic Diseases, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
Norton S; The Centre for Rheumatic Diseases, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.; Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Matcham F; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Pokaż więcej
Źródło:
JMIR formative research [JMIR Form Res] 2021 Mar 09; Vol. 5 (3), pp. e22473. Date of Electronic Publication: 2021 Mar 09.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia.
Autorzy:
D'Cruz RF; Centre for Human and Applied Physiological Sciences, King's College London, London, UK.
Waller MD; Centre for Human and Applied Physiological Sciences, King's College London, London, UK.; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Perrin F; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Periselneris J; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Norton S; Centre for Rheumatic Disease, King's College London, London, UK.
Smith LJ; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Patrick T; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Walder D; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Heitmann A; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Lee K; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Madula R; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
McNulty W; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Macedo P; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Lyall R; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Warwick G; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Galloway JB; Centre for Rheumatic Disease, King's College London, London, UK.
Birring SS; Centre for Human and Applied Physiological Sciences, King's College London, London, UK.; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Patel A; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Patel I; Centre for Human and Applied Physiological Sciences, King's College London, London, UK.; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Jolley CJ; Centre for Human and Applied Physiological Sciences, King's College London, London, UK.; Dept of Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Pokaż więcej
Źródło:
ERJ open research [ERJ Open Res] 2021 Feb 08; Vol. 7 (1). Date of Electronic Publication: 2021 Feb 08 (Print Publication: 2021).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report.
Autorzy:
Buckland MS; Department of Clinical Immunology, Barts Health, London, UK. .; UCL GOSH Institute of Child Health Division of Infection and Immunity, Section of Cellular and Molecular Immunology, London, UK. .
Galloway JB; Centre for Rheumatic Diseases, King's College London, London, UK.
Fhogartaigh CN; Department of Infection, Barts Health NHS Trust, London, UK.
Meredith L; Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
Provine NM; Peter Medawar Building for Pathogen Research, South Parks Rd, Oxford, OX1 3SY, UK.; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Bloor S; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Ogbe A; Peter Medawar Building for Pathogen Research, South Parks Rd, Oxford, OX1 3SY, UK.; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Zelek WM; Systems Immunity Institute and Dementia Research Institute, Cardiff University, Cardiff, UK.
Smielewska A; Division of Virology, Department of Pathology, University of Cambridge, Addenbrookes Hospital, Cambridge, UK.; PHE - Public Health England Laboratory, Cambridge. Box 236, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK.
Yakovleva A; Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
Mann T; Medical Research Council Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge, CB2 1QW, UK.
Bergamaschi L; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Turner L; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Mescia F; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Toonen EJM; R&D Department, Hycult Biotechnology, Frontstraat 2A, 5405 PB, Uden, The Netherlands.
Hackstein CP; Peter Medawar Building for Pathogen Research, South Parks Rd, Oxford, OX1 3SY, UK.; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Akther HD; Peter Medawar Building for Pathogen Research, South Parks Rd, Oxford, OX1 3SY, UK.; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Vieira VA; Peter Medawar Building for Pathogen Research, South Parks Rd, Oxford, OX1 3SY, UK.; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Ceron-Gutierrez L; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.
Periselneris J; Respiratory Department, King's College Hospital NHS Foundation Trust, UK. Department of Clinical Virology, Addenbrookes, UK.
Kiani-Alikhan S; Department of Clinical Immunology, Barts Health, London, UK.
Grigoriadou S; Department of Clinical Immunology, Barts Health, London, UK.
Vaghela D; Department of Infectious Diseases, Cambridge University Hospitals NHS Trust, Cambridge, UK.
Lear SE; Department of Immunology, Cambridge University Hospitals NHS Trust, Cambridge, UK.
Török ME; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Cambridge University Hospitals NHS Foundation Trust, Department of Microbiology, Cambridge, UK.
Hamilton WL; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Stockton J; Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
Quick J; Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
Nelson P; Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.
Hunter M; Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.
Coulter TI; Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.; Regional Immunology Service, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.
Devlin L; Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.; Regional Immunology Service, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.
Bradley JR; NIHR BioResource and NIHR Cambridge Biomedical Research Centre, Cambridge Biomedical Campus, Cambridge, UK.
Smith KGC; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Ouwehand WH; Department of Haematology, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.; NHS Blood and Transplant, Cambridge Biomedical Campus, Cambridge, UK.
Estcourt L; NHS Blood and Transplant, Oxford, UK.
Harvala H; NHS Blood and Transplant, London, UK.
Roberts DJ; NHS Blood and Transplant, Oxford, UK.; Radcliffe Department of Medicine and BRC Haematology Theme, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Wilkinson IB; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Screaton N; Radiology, Papworth Hospital, Cambridge, UK.
Loman N; Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
Doffinger R; Respiratory Department, King's College Hospital NHS Foundation Trust, UK. Department of Clinical Virology, Addenbrookes, UK.
Lyons PA; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Morgan BP; Systems Immunity Institute and Dementia Research Institute, Cardiff University, Cardiff, UK.
Goodfellow IG; Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
Klenerman P; Peter Medawar Building for Pathogen Research, South Parks Rd, Oxford, OX1 3SY, UK.; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Lehner PJ; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.; Department of Infectious Diseases, Cambridge University Hospitals NHS Trust, Cambridge, UK.
Matheson NJ; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK. .; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK. .; Department of Infectious Diseases, Cambridge University Hospitals NHS Trust, Cambridge, UK. .; NHS Blood and Transplant, Cambridge Biomedical Campus, Cambridge, UK. .
Thaventhiran JED; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK. .; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK. .; Medical Research Council Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge, CB2 1QW, UK. .; Cancer Research UK Cambridge Institute, Cambridge Biomedical Campus, Cambridge, UK. .
Pokaż więcej
Corporate Authors:
CITIID-NIHR COVID-19 BioResource Collaboration
MRC-Toxicology Unit COVID-19 Consortium
Źródło:
Nature communications [Nat Commun] 2020 Dec 14; Vol. 11 (1), pp. 6385. Date of Electronic Publication: 2020 Dec 14.
Typ publikacji:
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenosine Monophosphate/*analogs & derivatives
Alanine/*analogs & derivatives
Immunity, Humoral/*drug effects
SARS-CoV-2/*drug effects
Adenosine Monophosphate/therapeutic use ; Adult ; Alanine/therapeutic use ; Antiviral Agents/therapeutic use ; COVID-19/virology ; Fever/prevention & control ; Humans ; Immunity, Humoral/immunology ; Lymphocyte Count ; Male ; SARS-CoV-2/immunology ; SARS-CoV-2/physiology ; Treatment Outcome
Czasopismo naukowe
Tytuł:
A systematic review of CXCL13 as a biomarker of disease and treatment response in rheumatoid arthritis.
Autorzy:
Bechman K; Centre of Rheumatic Diseases, Weston Education Centre, King's College London, Room 3.46, Third Floor, London, SE5 9RJ, UK. .
Dalrymple A; Centre of Rheumatic Diseases, Weston Education Centre, King's College London, Room 3.46, Third Floor, London, SE5 9RJ, UK.
Southey-Bassols C; Centre of Rheumatic Diseases, Weston Education Centre, King's College London, Room 3.46, Third Floor, London, SE5 9RJ, UK.
Cope AP; Centre of Rheumatic Diseases, Weston Education Centre, King's College London, Room 3.46, Third Floor, London, SE5 9RJ, UK.
Galloway JB; Centre of Rheumatic Diseases, Weston Education Centre, King's College London, Room 3.46, Third Floor, London, SE5 9RJ, UK.
Pokaż więcej
Źródło:
BMC rheumatology [BMC Rheumatol] 2020 Nov 02; Vol. 4 (1), pp. 70. Date of Electronic Publication: 2020 Nov 02.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
How achievable are COVID-19 clinical trial recruitment targets? A UK observational cohort study and trials registry analysis.
Autorzy:
Cunniffe NG; Department of Clinical Neurosciences, Cambridge University, Cambridge, UK.
Gunter SJ; Harvard Medical School, Harvard University, Boston, Massachusetts, USA.
Brown M; Division of Infection, University College London Hospital NHS Trust, London, UK.
Burge SW; Cancer Research UK Urological Malignancies Programme, Department of Oncology, University of Cambridge, Cambridge, UK.
Coyle C; Department of Cardiology, Hammersmith Hospitals NHS Trust, London, UK.
De Soyza A; Respiratory Medicine, Freeman Hospital, Newcastle upon Tyne, UK.
Dymond T; Department of Infection and Inflammation Research, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Esmail H; Hospital for Tropical Diseases, University College London Hospitals NHS Foundation Trust, London, UK.; MRC Clinical Trials Unit, University College London, London, UK.; Institute for Global Health, University College London, London, United Kingdom.
Francis DP; Faculty of Medicine, National Heart & Lung Institute, Imperial College London, London, UK.
Galloway J; Department of Respiratory Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Galloway JB; Centre for Rheumatic Diseases, Kings College London, London, UK.
Gkrania-Klotsas E; Department of Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Greenaway J; Research and Development, North Tees Hospital, Stockton-on-Tees, UK.
Katritsis G; National Heart and Lung Institute, Imperial College London, London, UK.
Kanagaratnam P; Department of Cardiology, St Marys Hospital, Imperial College Healthcare NHS Trust, London, UK.
Knolle MD; Department of Respiratory Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Leonard K; Cambridge Urology Translational Research and Clinical Trials Department, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
McIntyre ZC; School of Clinical Medicine, Office for Translational Research, University of Cambridge, Cambridge, UK.
Prudon B; Department of Respiratory Medicine, North Tees Hospital, Stockton-on-Tees, UK.
Rampling T; Division of Pathology, University College London Hospital NHS Trust, London, United Kingdom.
Torok ME; University of Cambridge, Cambridge, UK.
Warne B; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK.
Yates M; Centre for Rheumatic Diseases, Kings College London, London, UK.
Matheson NJ; Department of Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK.; NHS Blood and Transplant, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.
Su L; MRC Biostatistics Unit, University of Cambridge School of Clinical Medicine, Cambridge Institute of Public Health, Cambridge, United Kingdom.
Villar S; MRC Biostatistics Unit, University of Cambridge School of Clinical Medicine, Cambridge Institute of Public Health, Cambridge, United Kingdom.
Stewart GD; Cancer Research UK Urological Malignancies Programme, Department of Oncology, University of Cambridge, Cambridge, UK.; Department of Surgery, University of Cambridge, Cambridge, UK.
Toshner M; Department of Medicine, University of Cambridge, Cambridge, UK .; NIHR Respiratory Translational Research Collaboration, Cambridge, UK.
Pokaż więcej
Źródło:
BMJ open [BMJ Open] 2020 Oct 05; Vol. 10 (10), pp. e044566. Date of Electronic Publication: 2020 Oct 05.
Typ publikacji:
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomedical Research*/organization & administration
Biomedical Research*/statistics & numerical data
Coronavirus Infections*/epidemiology
Coronavirus Infections*/therapy
Pandemics*
Patient Selection*
Pneumonia, Viral*/epidemiology
Pneumonia, Viral*/therapy
Randomized Controlled Trials as Topic*/methods
Randomized Controlled Trials as Topic*/statistics & numerical data
Betacoronavirus/isolation & purification ; COVID-19 ; Eligibility Determination ; Female ; Health Services Accessibility/statistics & numerical data ; Hospitalization/statistics & numerical data ; Humans ; Male ; Middle Aged ; Prospective Studies ; Registries/statistics & numerical data ; SARS-CoV-2 ; United Kingdom
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies